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OBJECTIVES: The purpose of this study was to conduct a statis-
tical mapping between standard assessments of disease severity in
ulcerative colitis (UC) using the ulcerative colitis disease activity
index (UCDAI) and a patient reported generic health-related
utility instrument to estimate patient preference-based health
utility. METHODS: Multinomial logistic regression was used to
estimate response probabilities to each of the ﬁve domains of the
EuroQol-5D index instrument (EQ-5D) from assessments of UC
severity using the original UCDAI and an abbreviated (ie. No
endoscopy) UCDAI instrument in patients enrolled into a clinical
trial studying the use of oral/rectal mesalazine combination main-
tenance therapy. Predicted EQ-5D health utility was estimated by
Monte Carlo bootstrap simulation. The predictive ability of the
response mapping was assessed by comparing estimated and
directlymeasured utility derived from the UK tariff (Dolan, 1997).
RESULTS:Evaluable datawere available for 128 patients, 59%of
whom were male, and for which the median age at screening
was 43.5 years (IQR 30 to 54). Using UCDAI item responses as
predictor variables, the percentage of variance in domain response
attributable to predictor variable change ranged from 20.4%
(ANXIETY/DEPRESSION) to 42.5.5% (SELF CARE). Summary
UCDAI score was a less effective predictor of the same domains
(R2 = 13.2% and 20.4 respectively). Items from the abbreviated
UCDAI (no endoscopy score) showed comparable explanatory
performance (R2 range 21.3% to 38.0%). The mean utility pre-
dicted by the UCDAI item algorithm was 0.844 (sd 0.104) and
0.852 (sd 0.175) by estimation directly from EQ-5D responses
(p = 0.238). The mean squared error (MSE) between the actual
and predicted utilities was 0.019. Predicted EQ-5D utility was
within 3% of the actual utility in 38.1% of cases and within 10%
of the actual utility in 58.5% of cases. CONCLUSIONS: In this
study response mapping of UC disease activity to EQ-5D domains
produced reliable estimates of preference-based health-related
utility. The near-identical explanatory power of models using
either the original or abbreviated UCDAI assessment suggests that
endoscopy adds little information to patient perception of UC
disease severity. The results from this study will enable future
investigators to generate health-related utility from the UCDAI in
trials where this data was not prospectively collected.
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BACKGROUND: Inﬂammatory Bowel Disease Questionnaire
(IBDQ) is a disease speciﬁc instrument widely used to assess
quality of life (QoL) of patients with inﬂammatory bowel disease
(IBD) particularly patients with Crohn’s Disease (CD) and Ulcer-
ative Colitis (UC). However, decision makers require preference
based utilities to allocate health care resources when only QoL
data estimated using IBDQ is available. OBJECTIVES: To derive
an algorithm capable of generating preference based utilities for
IBD patients based on their QoL assessed using IBDQ and to
estimate its applicability to CD and UC patients separately.
METHODS: The sample consisted of Spanish IBD patients com-
pleting the Spanish versions of IBDQ and EQ-5D. EQ-5D scores
were estimated using the Spanish tariffs. Algorithms for estimating
utilities based on responses to IBDQ were derived for combined
IBD population and then separately for CD and UC patients using
a stepwise forward OLS regression. The algorithms consisted of a
combination of important patient characteristics and signiﬁcant
IBDQ domains. Adjusted R-square and root mean-squared error
(RMSE) were used to select the most appropriate algorithm. The
ability of the algorithm based on IBD patients to predict
the utilities for CD and UC patients was assessed. RESULTS: The
sample consisted of 424 IBD patients with a mean age of 35 years
and median disease duration of 4.33 years. Disease severity
(Harvey-Bradshaw/Rachmilewitz index) was correlated with
IBDQ (r = -0.75) and EQ-5D (r = -0.58). CONCLUSIONS: This
regression approach enables clinicians and decision makers to
estimate preference based utilities from IBDQ in IBD patients. The
algorithm appears to be fairly robust based on the explanatory
power of the algorithm and validation results.
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OBJECTIVES: The study aims to document the psychometric
characteristics of the Spanish translation of two questionnaires:
RDQ to evaluate GERD symptoms and GIS to evaluate impact of
symptoms in patients’ daily life. METHODS: A psychometric
validation study to evaluate two self-administered questionnaires
in 300 patients with reﬂux symptoms. Each investigator con-
ducted the study on two consultations (basal/2 weeks visits) in
one patient with GERD diagnosis and no predictable changes in
their health status in the following 16 days (reliability group) and
4 new patients to be treated with a known efﬁcient treatment
(sensibility group). RESULTS: A total of 281 evaluable patients
were analysed; mean age was 55,6 years (95%CI: 53.9–57.3) and
48% were male. Factibility: More than 80% of patients complete
the RDQ (100% Visit 1 and 99.6% Visit 2) and 99.3% GIS
questionnaire (both visits). Only 0.71% patients left one missing
item in the RDQ and 1.07% in the GIS questionnaire. Validity:
RDQ and GIS questionnaires are able to discriminate frequency
and sensibility of symptoms (p < 0.0001). Reliability of internal
consistence: Both questionnaires have a good internal consis-
tence. RDQ showed an alpha value (Cronbach)  0.70 and
CCI  0.60 in all domains. GIS questionnaire had an alpha
value  0.69 and CCI  0.45 in all domains. Sensibility to
change (sensibility group): Both questionnaires show a high sen-
sibility to the patient recovery. When the either the physician or
the patient found an improvement in the health at two weeks,
the differences in the scores were always statistically signiﬁcant
(p < 0.0001). CONCLUSIONS: RDQ and GIS questionnaires
have satisfactory reliability, validity and sensibility to change.
Both tools are easy to use and suitable to evaluate the impact and
the severity of reﬂux symptoms in GERD patients.
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OBJECTIVES: To deﬁne the scoring and assess the psychometric
properties of a newly developed questionnaire measuring the
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impact of child gastroenteritis on parents. METHODS: A litera-
ture review was conducted to create the ﬁrst conceptual model.
Semi-directive interviews of 10 parents were conducted and
analysed to create items. A 54-item self-administered question-
naire was simultaneously developed in French and UK English
and cognitive debrieﬁngs were conducted with 5 parents. The
questionnaire was linguistically validated in Spanish, Italian and
Polish and included in an observational and prospective study
conducted with 302 parents of children under 5 presenting at the
general practitioner/paediatrician site with acute gastroenteritis.
Multitrait analysis and item content were used to conﬁrm the
dimensions and deﬁne the scoring of the questionnaire. Internal
consistency reliability (Cronbach’s alpha), ﬂoor and ceiling
effects, scale-scale correlations and criterion validity of the result-
ing version were assessed. RESULTS: The ﬁnal version of the
questionnaire consists of 44 items in ﬁve dimensions: “Symptom
Severity” (13 items), “Parents’ Worries due to Symptoms” (8
items), “Child’s Behaviour” (6 items), “Impact on Parents’ Daily
Activities” (10 items) and “Parents’ Distress” (7 items). Higher
scores indicate higher levels of negative feelings. All the scores
presented good psychometric properties: no dimension had a
ﬂoor or ceiling effect, Cronbach’s alpha ranged from 0.78 to 0.85
showing a good internal consistency reliability, and scale-scale
correlations ranged from 0.41 to 0.67 showing consistency but
no redundancy between the dimensions. Correlations with
Clark’s and Vesikari’s scores showed a good criterion validity.
The more severe the gastroenteritis episode, the higher the scores
of the questionnaire. CONCLUSIONS: The “Impact of child
gastroenteritis on parents” questionnaire allows a very complete
overview of how an episode of severe gastroenteritis impacts the
parents of the ill child. The questionnaire is a valid and reliable
instrument, suitable for future studies.
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OBJECTIVES: To compare the ability of individual and societal
preference scores based on the EQ-5D to identify active inﬂam-
matory bowel disease (IBD) in Germany. METHODS: Members
of the German IBD Association documented Health-Related
Quality of Life (hrQoL) with the EQ5-D and other disease-
related factors. Inactive or active disease was based on calculated
IBD activity indices. Disease activity was also classiﬁed (present
or absent) according to sick-leave and hospitalizations, docu-
mented retrospectively (three months) and prospectively (four
weeks). EQ-5D index scores were calculated using British (EQ-
5DBT) and German (EQ-5DGT) tariffs. Differences in EQ VAS
and EQ-5D index scores between patient groups differing in
disease activity, sick-leave and hospitalizations were determined
by effect size (ES) and bootstrap test for the standardised differ-
ence between the means. ES and bootstrap-test probability are
always reported in this consecutive order: EQ VAS, EQ-5DBT
and EQ-5DGT. RESULTS: A total of 527 retrospective and 483
prospective questionnaires were analysed. Retrospectively, 20%
reported sick-leave, 7% hospitalisation, whereas prospectively,
12% reported sick-leave, 2% hospitalisation. 39% had active
disease. All preference scores differed signiﬁcantly between
patients with active and inactive disease (ES: 13.72, 11.47, 9.56;
p: 0.0001(all)). Retrospectively, ES of preference scores of
patients differing in sick-leave (ES: 4.35, 4.51, 3.37; p: 0.0001,
0.0001, 0.002) and hospitalisation (ES: 2.07, 2.17, 1.91; p:
0.047, 0.047, 0.081) were large. Prospectively, the ES of prefer-
ence scores for sick-leave groups (ES: 4.34, 4.32, 3.00; p: 0.0001,
0.0002, 0.0119) and hospitalisation (ES: 3.45, 3.08, 2.50;
p: 0.014, 0.022, 0.061) were also large. CONCLUSIONS: In
German IBD subjects, the ES of all preference scores was large
regarding disease-activity, sick-leave and hospitalisation both ret-
rospectively and prospectively. Bootstrap-test probability showed
that the EQ-5DGT discriminated less well between the groups
than the other preference scores.
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OBJECTIVES: Limited epidemiological data are available con-
cerning gastroesophageal reﬂux disease (GERD). The aims of
this study were to estimate the proportion of patients with
GERD-related symptoms in primary care, and to describe the
symptom burden and clinical management of the disease.
METHODS: RANGE-Greece was part of a European pro-
gramme, which was conducted in six countries and comprised
similar cross-sectional studies run in parallel. RANGE-Greece
recruited retrospectively identiﬁed patients who visited an ofﬁce-
based gastroenterologist for a GERD-related reason during a
4-month period (index visit). Consenting subjects were invited to
attend a study visit. Data collection was performed for both the
index and study visits. Patient-reported outcomes were collected
by means of validated questionnaires (RDQ, XQS, GIS, WPAI-
GERD). RESULTS: From the 29,903 patients identiﬁed by 23
gastroenterologists, 2116 (7.1%) had GERD-related reasons for
the index visit. 505 randomly selected patients, who consented
to participation, comprised the analysed population. Mean
(SD) age was 52 (14) years; 52.5% were women. The main
reasons for the index visit were: recurrent symptoms after a
remission period (41.8%), new reﬂux symptoms in a treatment-
naïve patient (35.6%), persistence of previous reﬂux symptoms
(10.9%), and follow-up visit in an asymptomatic patient (5.5%).
57.4% of patients had an endoscopic diagnosis. At the index
visit, 99.8% of patients were prescribed a proton pump inhibi-
tor. The study visit was performed after a median of 6.5 months.
A total of 40.6% of patients had not changed treatment,
whereas 23.6% and 21.0% were still suffering from heartburn
and acid regurgitation, respectively (frequency 2 days the pre-
vious week). Symptom severity was moderate in 29.3% and
22.8% and severe in 3.2% and 4.2% of patients with heartburn
and acid regurgitation, respectively. CONCLUSIONS: Despite
medical attention and treatment a considerable proportion of
patients did not achieve an acceptable control of GERD-related
symptoms.
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OBJECTIVES: GERD is associated with obesity, age and gender
in several studies. The GERD impact scale is a validated one-page
self-administered questionnaire that asks patients about GERD
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